IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings

IDBS and Alchemi partnered to connect AI agents with data in the IDBS Polar platform, creating a governed data foundation that enables reliable, compliant agentic AI use throughout drug development.

The post IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings appeared first on GEN - Genetic Engineering and Biotechnology News.